» Articles » PMID: 17126901

The Influence of Polymeric Properties on Chitosan/siRNA Nanoparticle Formulation and Gene Silencing

Overview
Journal Biomaterials
Date 2006 Nov 28
PMID 17126901
Citations 96
Authors
Affiliations
Soon will be listed here.
Abstract

We have previously introduced the use of the biomaterial chitosan to form chitosan/siRNA nanoparticles for gene silencing protocols. This present study shows that the physicochemical properties (size, zeta potential, morphology and complex stability) and in vitro gene silencing of chitosan/siRNA nanoparticles are strongly dependent on chitosan molecular weight (Mw) and degree of deacetylation (DD). High Mw and DD chitosan resulted in the formation of discrete stable nanoparticles approximately 200 nm in size. Chitosan/siRNA formulations (N:P 50) prepared with low Mw (approximately 10 kDa) showed almost no knockdown of endogenous enhanced green fluorescent protein (EGFP) in H1299 human lung carcinoma cells, whereas those prepared from higher Mw (64.8-170 kDa) and DD (approximately 80%) showed greater gene silencing ranging between 45% and 65%. The highest gene silencing efficiency (80%) was achieved using chitosan/siRNA nanoparticles at N:P 150 using higher Mw (114 and 170 kDa) and DD (84%) that correlated with formation of stable nanoparticles of approximately 200 nm. In conclusion, this work confirms the application of chitosan as a non-viral carrier for siRNA and the importance of polymeric properties for the optimisation of gene silencing using chitosan/siRNA nanoparticles.

Citing Articles

Advances and prospects of RNA delivery nanoplatforms for cancer therapy.

Attia M, Kijanka G, Nguyen N, Zhang J, An H Acta Pharm Sin B. 2025; 15(1):52-96.

PMID: 40041887 PMC: 11873661. DOI: 10.1016/j.apsb.2024.09.009.


siRNA silencing and hypoxia challenge indicate that the function of common carp (Cyprinus carpio) hif-1αb genes are tightly linked to hif-1αa and hif-3α genes.

Wang X, Zhai H, Guo J, Wang X, Gu L, Li T BMC Genomics. 2024; 25(1):1203.

PMID: 39695393 PMC: 11657654. DOI: 10.1186/s12864-024-11141-0.


The application of nanoparticles in delivering small RNAs for cancer therapy.

Zhou T, Qiu J, Han X, Zhang X, Wang P, Xie S Discov Oncol. 2024; 15(1):500.

PMID: 39331172 PMC: 11436575. DOI: 10.1007/s12672-024-01341-1.


Chitosan siRNA Nanoparticles Produce Significant Non-Toxic Functional Gene Silencing in Kidney Cortices.

Alameh M, Tavakoli Naeini A, Dwivedi G, Lesage F, Buschmann M, Lavertu M Polymers (Basel). 2024; 16(17).

PMID: 39274180 PMC: 11398103. DOI: 10.3390/polym16172547.


Impact of Peptide Sequence on Functional siRNA Delivery and Gene Knockdown with Cyclic Amphipathic Peptide Delivery Agents.

Jagrosse M, Baliga U, Jones C, Russell J, Garcia C, Najar R Mol Pharm. 2023; 20(12):6090-6103.

PMID: 37963105 PMC: 10698724. DOI: 10.1021/acs.molpharmaceut.3c00455.